Rocket One Inc. Employee Benefits and Share-based Compensation
Rocket One Inc. (RKTO) reported Employee Benefits and Share-based Compensation of $184.54 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2023-11-13
- Rocket One Inc. employee benefits and share-based compensation for the quarter ending 2023-09-30 was $184.54K.
- Rocket One Inc. employee benefits and share-based compensation for the quarter ending 2022-06-30 was $15.54K, a 48.82% decline year-over-year.
- Rocket One Inc. employee benefits and share-based compensation for the quarter ending 2022-03-31 was $577.44K, a 48.72% decline year-over-year.
- Rocket One Inc. employee benefits and share-based compensation for the quarter ending 2021-12-31 was $1.31M.
- Rocket One Inc. employee benefits and share-based compensation for fiscal 2021 was $1.32M, a 79.31% increase from fiscal 2020.
- Rocket One Inc. employee benefits and share-based compensation for fiscal 2020 was $737.75K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 9 month as first filed | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $184.54K 10-Q · filed 2023-11-13 | $188.50K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $15.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $592.98K 10-Q · filed 2022-08-12 | $1.90M derived: sum of 3 quarters · filed 2022-08-12 | $759.40K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | $577.44K 10-Q · filed 2022-05-12 | $1.88M derived: sum of 2 quarters · filed 2022-05-12 | $743.86K derived: sum of 3 quarters · filed 2022-11-10 | $774.22K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $166.42K derived: sum of 2 quarters · filed 2022-11-10 | $196.78K derived: sum of 3 quarters · filed 2022-11-10 | $1.32M 10-K · filed 2022-03-30 | |
| 2021-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.11M derived: sum of 2 quarters · filed 2022-11-10 | $16.53K 10-Q · filed 2022-11-10 | $124.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $30.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.16M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $1.13M 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $737.75K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |